Gain Therapeutics, Inc.
GANX
$1.72
-$0.11-6.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.08M | 16.54M | 20.84M | 8.81M | 6.69M |
| Total Receivables | 1.03M | 994.60K | 802.70K | 788.60K | 1.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 853.90K | 687.90K | 596.80K | 921.30K | 1.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.97M | 18.22M | 22.24M | 10.52M | 9.31M |
|
|
|||||
| Total Current Assets | 14.97M | 18.22M | 22.24M | 10.52M | 9.31M |
| Net Property, Plant & Equipment | 313.90K | 355.00K | 409.00K | 270.00K | 329.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 76.80K | 90.00K | 102.80K | 114.60K | 127.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.50K | 71.60K | 70.00K | 69.80K | 70.00K |
| Total Assets | 15.42M | 18.74M | 22.82M | 10.97M | 9.83M |
|
|
|||||
| Total Accounts Payable | 1.22M | 1.52M | 825.00K | 1.58M | 2.71M |
| Total Accrued Expenses | 1.91M | 2.09M | 2.26M | 2.29M | 2.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 233.10K | 216.90K | 220.70K | 241.50K | 262.40K |
| Total Finance Division Other Current Liabilities | 69.70K | 66.70K | 43.10K | 57.60K | 47.90K |
| Total Other Current Liabilities | 69.70K | 66.70K | 43.10K | 57.60K | 47.90K |
| Total Current Liabilities | 3.43M | 3.89M | 3.35M | 4.17M | 5.20M |
|
|
|||||
| Total Current Liabilities | 3.43M | 3.89M | 3.35M | 4.17M | 5.20M |
| Long-Term Debt | 220.10K | 273.30K | 300.10K | 298.80K | 325.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 156.80K | 182.10K | 211.20K | 65.00K | 92.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 319.20K | 389.50K | 390.50K | 527.80K | 522.70K |
| Total Liabilities | 4.13M | 4.73M | 4.25M | 5.06M | 6.14M |
|
|
|||||
| Common Stock & APIC | 121.93M | 119.97M | 119.14M | 102.16M | 94.65M |
| Retained Earnings | -111.64M | -106.96M | -101.36M | -96.82M | -91.53M |
| Treasury Stock & Other | 1.00M | 997.00K | 776.90K | 563.20K | 584.10K |
| Total Common Equity | 11.29M | 14.01M | 18.56M | 5.91M | 3.70M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.29M | 14.01M | 18.56M | 5.91M | 3.70M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.29M | 14.01M | 18.56M | 5.91M | 3.70M |
|
|
|||||